- Home
- ORIC vs GPRE Comparison
ORIC vs GPRE Comparison
Compare ORIC & GPRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | GPRE |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.3M | 812.2M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ORIC | GPRE |
|---|---|---|
| Price | $8.20 | $17.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $19.73 | $12.57 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $2,091,680,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.85 |
| P/E Ratio | ★ N/A | $39.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.65 | $3.97 |
| 52 Week High | $14.93 | $18.94 |
Technical Indicators
Market Signals| Indicator | ORIC | GPRE |
|---|---|---|
| Relative Strength Index (RSI) | 31.58 | 52.98 |
| Support Level | $7.90 | $9.25 |
| Resistance Level | $13.89 | $17.94 |
| Average True Range (ATR) | 0.50 | 0.91 |
| MACD | -0.10 | -0.09 |
| Stochastic Oscillator | 4.87 | 32.91 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.